Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Summary
The purpose of this study is to compare the efficacy and safety of ICP-332 in moderate to severe chronic spontaneous urticaria subjects inadequately controlled by second generation H1-antihistamines
Official title: A Phase II/III Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of ICP-332 in Moderate to Severe Chronic Spontaneous Urticaria Subjects Inadequately Controlled by Second Generation H1-antihistamines
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
344
Start Date
2026-03
Completion Date
2028-09
Last Updated
2026-01-30
Healthy Volunteers
No
Conditions
Interventions
ICP-332 Tablets
ICP-332 will be administered as tablet for 12 weeks
ICP-332 placebo Tablets
ICP-332 placebo will be administered as tablet for 12 weeks
ICP-332 Tablets
ICP-332 will be administered as tablet for 24 weeks
Locations (30)
Bengbu Medical University First Affiliated Hospital
Bengbu, Anhui, China
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Chongqing Traditional Chinese Medicine Hospital
Chongqing, Chongqing Municipality, China
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The Second Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Henan Provincial People's Hospital
Zhengzhou, Henan, China
Jingzhou Central Hospital
Jingzhou, Hubei, China
Shiyan Taihe Hospital
Shiyan, Hubei, China
Xiangya hospital central south university
Changsha, Hunan, China
Suzhou Municipal Hospital
Suzhou, Jiangsu, China
Wuxi No. 2 People's Hospital
Wuxi, Jiangsu, China
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, China
The First Hospital of Jilin University
Changchun, Jilin, China
Shenyang Hospital of Integrated Traditional Chinese and Western Medicine （Shenyang Seventh People's Hospital）
Shenyang, Liaoning, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Jinan Central Hospital
Jinan, Shandong, China
Shandong Provincial Hospital for Skin Disease, Shandong First Medical University
Jinan, Shandong, China
Shanghai Skin Disease Hospital
Shanghai, Shanghai Municipality, China
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Chengdu Second People's Hospital
Chengdu, Sichuan, China
Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Hangzhou Third People's Hospital
Hangzhou, Zhejiang, China
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Hangzhou, Zhejiang, China